The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of the prognostic significance of circulating tumor DNA (ctDNA) in metastatic castrate-resistant prostate cancer (mCRPC).
 
Justin Shaya
No Relationships to Disclose
 
James Michael Randall
No Relationships to Disclose
 
Frederick E. Millard
No Relationships to Disclose
 
Razelle Kurzrock
Leadership - CureMatch
Stock and Other Ownership Interests - CureMatch; IDbyDNA; Soluventis
Consulting or Advisory Role - Actuate Therapeutics; Gaido; Loxo; NeoMed; Roche; Soluventis; XBiotech
Speakers' Bureau - Roche
Research Funding - Foundation Medicine (Inst); Genentech (Inst); Grifols (Inst); Guardant Health (Inst); Incyte (Inst); Konica Minolta (Inst); Merck Serono (Inst); OmniSeq (Inst); Pfizer (Inst); Sequenom (Inst)
 
J Kellogg Parsons
Stock and Other Ownership Interests - Johnson & Johnson; Omega Healthcare Investors; Pfizer; Urigen Pharmaceuticals
Honoraria - Sophiris Bio
Travel, Accommodations, Expenses - Sophiris Bio
Other Relationship - MDxHealth
 
Pablo Tamayo
No Relationships to Disclose
 
Rana R. McKay
Consulting or Advisory Role - Astellas Medivation; Bristol-Myers Squibb; Dendreon; Exelixis; Janssen; Novartis; Pfizer; Tempus
Research Funding - Bayer (Inst); Pfizer (Inst)